NVID Finalizes Agreement for Bangladesh Distribution

ARCHIVED 2002–2016: Originally distributed via the eWire press wire service. Preserved as historical record.

SUBSCRIBE/UNSUBSCRIBE |

Conservation & Wildlife

Corporate Responsibility

Science & Technology

Syndication Partners

**************************************************************************

E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE E-WIRE PRESS RELEASE

**************************************************************************

For Immediate Release

NVID Finalizes Agreement for Bangladesh Distribution

FLORIDA, CLEARWATER, May. 2 -/E-Wire/-- NVID International, Inc. (Pink Sheets:NVID) today announced that a three year Distribution Agreement has been signed between NVID International, Inc. and Eon Animal Health Products Limited / Petrochem Limited of Dhaka, Bangladesh for the distribution of the company's complete line of ionization products.

The ionization equipment lineup includes the company's U.S. Patent No. 6,017,461 RMS ionization system for disinfecting water supplies to hospitals, schools, public buildings, and small municipalities; the IDS 90 and IDS 400 ionization systems for smaller water treatment applications, and the complete line of Superior Aqua Enterprises Sarasota, Florida ionization equipment for agricultural applications replacing traditional fungicides, herbicides and algaecides in a number of niche markets.

David Larson, NVID's President commented, "Bangladesh has a population of 127 million people all living in a country the size of the state of Wisconsin...and they don't have a clear cost-effective strategy to disinfect water. I believe our complete line of ionization technologies that will be distributed by Eon Animal Health Products Limited / Petrochem Limited will be part of the solution.'

Separate agreements are being negotiated between NVID and Eon Animal Health Products Limited / Petrochem Limited for specific market applications with NVID's U.S. patented, non-toxic disinfectant Axenohl. Additionally, a proprietary absorbent process for arsenic removal is also being negotiated between the two companies, in which NVID is currently in negotiations with a U.S. based company for certain marketing rights to the proprietary arsenic removal technology.

As previously announced in a March 8, 2001 press release, the U.S. Patent and Trademark Office issued U.S. Patent No. 6,197,814 for the product known as Axenohl. NVID owns the rights to the disinfectant by assignment and is now in the process of considering national and international distributors for distribution of the product.

Axenohl is a revolutionary anti-microbial technology that uses the biocidal properties of ionic silver to kill bacteria and viruses. The disinfection efficacy of Axenohl has been well documented by independent testing laboratories. Axenohl eliminates the following test organism strains all within one minute and 99.9999% efficacy.

Pseudomonas aeruginosa ATCC 15442 Staphylococcus aureus ATCC 6538 Salmonella cholerasuis ATCC 10708 E. Coli ATCC 0157:H7 Listeria monocytogenes ATCC 11543 Enterococcus faecium ATCC 11543 Rhinovirus (common colds) Rotavirus (infectious diarrhea) Vancomycin-resistant-enterococci (VRE)

Target markets for NVID's patented ionization disinfection technologies include; hospital and nursing home water systems, point-of-use / point-of-entry; municipal, commercial and residential drinking water systems, FDA compliant consumer products, pools / spas, cisterns / wells, veterinary, horticulture, agriculture and food processing applications.

About NVID International, Inc.

NVID International, Inc. based in Clearwater, Florida manufactures and markets patented ionization disinfection technologies that substantially reduce or replace traditional disinfectants such as quaternary ammonium salts, phenols, and chlorine or bromine based halogens.

The matters discussed in this news release are forward-looking statements with respect to the future activities of the Company. These forward-looking statements by their very nature involve risks and uncertainties and represent the Company's judgement as of the date of this release. NVID International, Inc. and Aqua Bio Technologies, Inc. can be reached at:

Corporate Office: 28163 U.S. 19 N. Suite 302 Clearwater, Florida 33761 Contact: David Larson Phone (727) 669-5005 Fax (727) 669-4701 e-mail [REDACTED-EMAIL]

Sales Office: 5153 Sandy Cove Avenue Sarasota, Florida 34242 Contact: Michael Redden Phone (941) 312-9100 Fax (941) 312-9300 e-mail [REDACTED-EMAIL]

NVID International Inc.

**************************************************************************

To Transmit Your News Over E-Wire, visit http://www.ewire.com or

call 1-[REDACTED-PHONE]. E-Wire Is Broadcast To Millions Of Readers Worldwide

**************************************************************************